Skip to content

Perspective Therapeutics CATX Return on invested capital

Return on invested capital at other companies

Eli Lilly logo
Eli LillyLLY
42%+16.6pp
Monopar Therapeutics logo
Monopar TherapeuticsMNPR
-38.6%
Immunome logo
ImmunomeIMNM
-746.6%+212pp
Viridian Therapeutics, Inc. logo
Viridian Therapeutics, Inc.VRDN
-76.5%+14.9pp
Lantheus Holdings logo
Lantheus HoldingsLNTH
19.9%-18.4pp
uniQure logo
uniQureQURE
-119%+424pp

Other financials

Income statement

See full
Revenue$2.2M+27.3%
Gross profit$738.0K+78.3%
Operating income-$28.3M-29.5%
Net income-$26.2M-44.1%
EPS (diluted)-$0.250.0%

Balance sheet

See full
Cash & equivalents$54.0M+21.5%
Total debt$4.2M+10.9%
Total equity$347.4M+22.1%
Total assets$410.8M+24.7%

Cash flow

See full
Operating cash flow-$31.5M-45.8%
CapEx$6.9M+47.3%
Free cash flow-$38.3M-46.1%

Valuation

See full
Market cap$342.14M+33.2%
Enterprise value$292.34M+35.2%
P/S34.2×+19.6×

Profitability

See full
Gross margin33.1%-7.1pp
Operating margin-292.7%-553pp
Net margin-218.4%-781pp
FCF margin-1,073.3%

Returns & leverage

See full
Return on equity-35.2%+2.3pp
Debt / equity0.0×
Current ratio8.7×-8.3×

Where this comes from

Calculated from Perspective Therapeutics’s reported figures.

Based on trailing twelve months.

The official record: Perspective Therapeutics’s 10-Q, filed May 11, 2026, on SEC EDGAR. View the filing →

Ask your AI about Perspective Therapeutics's return on invested capital.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Perspective Therapeutics's return on invested capital?
Perspective Therapeutics (CATX) reported return on invested capital of -44.3% in Q1 2026.
How has Perspective Therapeutics's return on invested capital changed year-over-year?
Perspective Therapeutics's return on invested capital increased by 25.6% year-over-year, from -59.6% to -44.3%.
What is the long-term trend for Perspective Therapeutics's return on invested capital?
Over 2 years (2020 to 2025), Perspective Therapeutics's return on invested capital has grown at a -19.6% compound annual growth rate (CAGR), from -85.2% to -55%.
What does return on invested capital mean?
Net operating profit after tax (operating income taxed at the effective rate) divided by average invested capital (debt plus equity minus cash). Measures the after-tax return on all capital put to work in the business, independent of capital structure.